Role of MGMT Methylation Status at Time of Diagnosis and Recurrence for Patients with Glioblastoma: Clinical Implications

BACKGROUND. MGMT methylation status represents a powerful prognostic factor in newly diagnosed glioblastoma (GBM). Recently, its role in recurrent tumors has also been suggested; however, few data investigating the stability of this biomarker during the clinical course of the disease are available....

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncologist
Autors principals: Brandes, Alba A., Franceschi, Enrico, Paccapelo, Alexandro, Tallini, Giovanni, De Biase, Dario, Ghimenton, Claudio, Danieli, Daniela, Zunarelli, Elena, Lanza, Giovanni, Silini, Enrico Maria, Sturiale, Carmelo, Volpin, Lorenzo, Servadei, Franco, Talacchi, Andrea, Fioravanti, Antonio, Pia Foschini, Maria, Bartolini, Stefania, Pession, Annalisa, Ermani, Mario
Format: Artigo
Idioma:Inglês
Publicat: AlphaMed Press 2017
Matèries:
Neuro‐Oncology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5388380/
https://ncbi.nlm.nih.gov/pubmed/28275120
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2016-0254
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars